QuickView for phosphoinositide 3- kinase (biogroup)

1. L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
2. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
3. Dicer1 knockout gene expression during Schwann cell development
4. Carotid arteries from atherogenic ApoE knockout mice with carotid artery injury
5. L1000 CMAP - Neural progenitor NPC cells treated with small molecule perturbagens

There were no matches for phosphoinositide 3- kinase

1. Rapamycin Treatment for Activated Phosphoinositide 3-Kinase δ Syndrome
2. Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Dia…
3. Bruton's Tyrosine Kinase (BTK) Inhibition in B-cell Lymphomas
4. Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer…
5. Phosphatidylinositol 3 Kinase and Mammalian Target of Rapamycin (PI3K-mTOR) in Advanced Cancer Patie…